Literature DB >> 25549585

Anticancer drugs: Finding the perfect combination.

Alexandra Flemming.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25549585     DOI： 10.1038/nrd4524

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Patient-derived models of acquired resistance can identify effective drug combinations for cancer.

Authors:  Adam S Crystal; Alice T Shaw; Lecia V Sequist; Luc Friboulet; Matthew J Niederst; Elizabeth L Lockerman; Rosa L Frias; Justin F Gainor; Arnaud Amzallag; Patricia Greninger; Dana Lee; Anuj Kalsy; Maria Gomez-Caraballo; Leila Elamine; Emily Howe; Wooyoung Hur; Eugene Lifshits; Hayley E Robinson; Ryohei Katayama; Anthony C Faber; Mark M Awad; Sridhar Ramaswamy; Mari Mino-Kenudson; A John Iafrate; Cyril H Benes; Jeffrey A Engelman
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728
  1 in total
  7 in total

1.  Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine.

Authors:  Dayue Darrel Duan; Zhong Wang; Bo-li Zhang; Yong-yan Wang
Journal:  Acta Pharmacol Sin       Date:  2015-06       Impact factor: 6.150

2.  Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model - Phenytoin and Valproate, Lamotrigine and Valproate.

Authors:  Kim Det Taing; Terence J O'Brien; David A Williams; Chris R French
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

3.  Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.

Authors:  Mengjie Rui; Yang Qu; Tong Gao; Yanru Ge; Chunlai Feng; Ximing Xu
Journal:  Int J Nanomedicine       Date:  2016-12-30

4.  Versatile and on-demand biologics co-production in yeast.

Authors:  Jicong Cao; Pablo Perez-Pinera; Ky Lowenhaupt; Ming-Ru Wu; Oliver Purcell; Cesar de la Fuente-Nunez; Timothy K Lu
Journal:  Nat Commun       Date:  2018-01-08       Impact factor: 14.919

Review 5.  Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance.

Authors:  Xiao Wei; Mingzhu Song; Weijie Li; Jing Huang; Guang Yang; Yi Wang
Journal:  Theranostics       Date:  2021-04-19       Impact factor: 11.556

6.  Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer.

Authors:  Yang Zheng; Lili Tang; Ziling Liu
Journal:  BMC Cancer       Date:  2021-12-10       Impact factor: 4.430

7.  (-)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer.

Authors:  Qingyuan Yang; Jianchun Wu; Yingbin Luo; Nan Huang; Ni Zhen; Yun Zhou; Fenyong Sun; Zhi Li; Qiuhui Pan; Yan Li
Journal:  Oncotarget       Date:  2016-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.